Stage IV Breast Inflammatory Carcinoma
2 clinical trials · Condition
◉ Watch Stage IV Breast Inflammatory Carcinoma
| Record | Firm | Date |
|---|---|---|
| Grapiprant and Eribulin for the Treatment of Metastatic Inflammatory Breast Cancer (NCT05041101) | M.D. Anderson Cancer Center | 2021-12-21 |
| Atezolizumab, Cobimetinib, and Eribulin in Treating Patients With Chemotherapy Resistant Metastatic Inflammatory Breast Cancer (NCT03202316) | M.D. Anderson Cancer Center | 2017-08-11 |
Track Stage IV Breast Inflammatory Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.